Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Claud B who wrote (2854)	3/19/1998 6:05:00 PM
From: Allan F	Read Replies (1) \| Respond to of 7041

<<<If you know anything about Mexico, then you would know that approval in Mexico is piggybacked by many South American countries and several in the Middle East.>>> Perhaps, but I think this announcement is the funniest thing I have read all week. I can't believe people think Mexican approval is worth of anything. If this is the best ZONA can do, and I was long I would be scared limp. Maybe we will begin to see some "sell on the news" ROFLMAO, Allan

To: Claud B who wrote (2854)	3/19/1998 6:29:00 PM
From: Bradpalm1	Read Replies (2) \| Respond to of 7041

<<If you know anything about Mexico, then you would know that approval in Mexico is piggybacked by many South American countries and several in the Middle East.>> I guess this then explains Wall Street's delirious response to this momentous news today. BTW, ALL of Europe is piggybacked onto the FDA's approval of Viagra at the end of this month since MCA approval will occur concurrently. Let's see....if Vasomax' latest clinical trial is concluded this September, then a standard 18 month FDA review following a possible NDA submission in October would put final possible approval of Vasomax somewhere in the year 2000. Gee, I hope Viagra's 2 year head start is enough time to corner the market. Bradpalm1